A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
Clinical trial NCT02580201 · COMPLETED
Trial details
- NCT number
- NCT02580201
- Sponsor
- Fidec Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-07-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.